79025533 - KRINGLE PHARMA

Information

• Trademark
• 79025533

• Source

• Serial Number

  79025533

• Registration Number

  3324812

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  November 14, 2005
  18 years ago

• Registration Date

  October 30, 2007
  16 years ago

• Transaction Date

  June 17, 2016
  8 years ago

• Status Date

  November 14, 2015
  8 years ago

• Published for Opposition Date

  August 14, 2007
  17 years ago

• Location Date

  October 30, 2007
  16 years ago

• Status Code

  404

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MORRIS, KRISTINA KLOIB

• Law Office Assigned Location Code

  M70

• Owners

  • KRINGLE PHARMA, INC

Case File Statements

• CC0000: The color(s) dark blue, light blue, black and white is/are claimed as a feature of the mark.
• CD0000: The colors dark blue and light blue appear in the design of the overlapping partial circles appearing above the wording KRINGLE PHARMA, getting lighter from left to right. The color dark blue appears in the wording KRINGLE PHARMA, and the color white appears in the background.
• D10000: KRINGLE PHARMA
• GS0051: Pharmaceutical veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases and cancer; sanitary preparations for medical use; central nervous system stimulants; stimulants in the nature of hair growth stimulant; antipyretic analgesics; anti-epileptics; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness preparations; preparations acting on the peripheral nervous system; local anesthetics; skeletal muscle relaxants; anhidrotics; pharmaceutical preparations for the treatment of autonomic nervous system diseases; antispasmodics; diaphoretics; pharmaceutical preparations for the treatment of sensory organs diseases; ophthalmic preparations; preparations for otic and nasal use, namely, nasal spray preparations, ear drops; antiallergic medications; antihistamines; cardiovascular treatment preparations; cardiotonics; antihypertensives; vasoconstrictors; pharmaceutical preparations for the treatment of vascular and venous diseases; cerebral hemorrhage prophylactic preparations; antiarrhythmic preparations; diuretics; pharmaceutical products for treating respiratory diseases; respiratory stimulants; anti-cough drops; anti-tussive expectorants; pharmaceutical preparations for the treatment of disease affecting digestive organs; gastrointestinal cleaning agents; evacuants; pharmaceutical preparations for oral care, namely, the treatment of oral inflammation, namely, stomatitis; emetics; medicines for dental purposes, namely, pharmaceutical preparations for the treatment of gingivostomatitis, alveolar abscess, alveoloclasia; antacids; intestinal regulators, namely, gastro-intestinal treatment preparations; antiemetics; castor oil for medical purposes; tooth prophylactics, namely, material for stopping teeth; cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; pharmaceutical preparations for the treatment of disease affecting uro-genitial and anal organs; oxytocics; anti-hemorrhoidals; emmenagogues; contraceptives; medicated skin care preparations, pharmaceutical preparations for dermatics and for purulence; pharmaceutical preparations for the treatment of skin infection; antimicrobials for dermatologic use; astringents; anti-inflammatories; analgesics; emollients, namely, medicinal creams for skin care; hair remedies, namely, medicated hair care preparations; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations; cod-liver oil drops; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations for medical purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium supplements; chondroitin preparations; protein and amino acid preparations for medical purposes; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, lupus erhthematosus; mineral preparations for medical use; anticoagulants; blood substitutes for human and veterinary use; blood plasma; hemostatics; pharmaceutical preparations for conditions affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for activating cellular function; chlorophyll preparations in the nature of dietary supplements; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; medicated skin care preparations for treating physically caused lesions; pharmaceutical preparations for the treatment of heatstroke; radiation sickness treating agents; pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn and side effect of anticancer drugs; immunosuppresants; pharmaceutical preparations for chlorine-detoxication; pharmaceutical preparations for arsenic-detoxication; pharmaceutical preparations for benzol-detoxication; antibiotic preparations; erythromycin preparations; chioramphenicol preparations; colistin-polymixin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous preparations; sulfonamide preparations; antileprotic preparations; biological preparations for medical purposes; antitoxic sera; antitoxins, mixed biological preparations for medical purposes; preparations for biological tests for medical purposes; toxoids; vaccines; preparations for destroying parasites; anthelmintics; ointment bases of the drugs for skin diseases, namely, itching, injury, burn, keloid, dermatitis, eczema, skin ulcer, psoriasis; diagnostic preparations for medical and veterinary use; contrast media for use with X-ray equipment; diagnostic reagents for medical use; diagnostic media for bacteriological cultures; radio-isotope markers for therapeutic or diagnostic use; opium alkaloid preparations; synthetic narcotics; coca alkaloid preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicides; insect-repellents; antiseptics

Case File Event Statements

• 6/17/2016 - 8 years ago

  38 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 7/10/2015 - 9 years ago

  37 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 6/23/2015 - 9 years ago

  36 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 6/23/2015 - 9 years ago

  35 - INVALIDATION PROCESSED Type: INPC

• 5/31/2015 - 9 years ago

  34 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 2/6/2015 - 9 years ago

  33 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 6/6/2014 - 10 years ago

  32 - CANCELLED SECTION 71 Type: C71T

• 1/13/2010 - 14 years ago

  31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/5/2009 - 15 years ago

  30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 2/5/2008 - 16 years ago

  29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 2/4/2008 - 16 years ago

  28 - FINAL DISPOSITION PROCESSED Type: FIMP

• 1/30/2008 - 16 years ago

  27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 10/30/2007 - 16 years ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/14/2007 - 17 years ago

  25 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/25/2007 - 17 years ago

  24 - NOTICE OF PUBLICATION Type: NPUB

• 7/10/2007 - 17 years ago

  23 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/10/2007 - 17 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/18/2007 - 17 years ago

  21 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 6/18/2007 - 17 years ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/7/2007 - 17 years ago

  19 - PAPER RECEIVED Type: MAIL

• 4/24/2007 - 17 years ago

  18 - NON-FINAL ACTION MAILED Type: CNRT

• 4/23/2007 - 17 years ago

  17 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/17/2007 - 17 years ago

  16 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 3/17/2007 - 17 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/16/2007 - 17 years ago

  14 - ASSIGNED TO LIE Type: ALIE

• 2/7/2007 - 17 years ago

  13 - PAPER RECEIVED Type: MAIL

• 1/13/2007 - 17 years ago

  12 - ATTORNEY REVIEW COMPLETED Type: ATRV

• 12/20/2006 - 17 years ago

  11 - CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Type: CREV

• 12/7/2006 - 17 years ago

  10 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV

• 11/22/2006 - 17 years ago

  9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 9/15/2006 - 18 years ago

  8 - REFUSAL PROCESSED BY IB Type: RFNT

• 8/29/2006 - 18 years ago

  7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 8/29/2006 - 18 years ago

  6 - REFUSAL PROCESSED BY MPU Type: RFRR

• 8/26/2006 - 18 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 8/25/2006 - 18 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/11/2006 - 18 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/11/2006 - 18 years ago

  2 - NEW APPLICATION ENTERED IN TRAM Type: NWAP

• 8/10/2006 - 18 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR